The bioresorbable agent is made from small irregularly shaped, dry gelatin particles designed for the embolization of hypervascular tumors and blood vessels.
New research findings could help explain the “obesity paradox,” wherein being overweight is linked to both improved outcomes in certain diseases and increased mortality rates in others.
In a new clinical study, the model was able to maintain its performance on scans completed on different types of CT equipment across multiple medical centers.
This new information on the pathogenesis of both conditions could be useful for the development of interventions targeted at slowing cognitive decline.
To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
